|
|
.
See Category: Neoplasms
See Header: Basal cell carcinoma skin/ left eyelid, including canthus
ICD-10 (CM) Code and Descriptor
|
C44.1192 |
Basal cell carcinoma of skin of left lower eyelid, including canthus
|
C441192 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 68.28%
|
18.71%
|
4.62%
|
2.90%
|
1.85%
|
1.45%
|
0.58%
|
0.42%
|
0.40%
|
0.16%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C44.1192*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
1,092
|
1,618
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
686
|
687
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
643
|
15,825
|
|
J3010
|
FENTANYL CITRATE INJECTION |
503
|
752
|
|
88331
|
PATH CONSLTJ SURG 1 BLK 1SPC |
469
|
750
|
|
17311
|
MOHS 1 STAGE H/N/HF/G |
459
|
470
|
|
J2405
|
ONDANSETRON HCL INJECTION |
370
|
1,521
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
322
|
667
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
316
|
1,712
|
|
14060
|
TIS TRNFR E/N/E/L 10 SQ CM/< |
314
|
314
|
|
J7120
|
RINGERS LACTATE INFUSION |
278
|
315
|
|
17312
|
MOHS ADDL STAGE |
270
|
335
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
256
|
927
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
223
|
1,412
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
210
|
423
|
|
15260
|
FTH/GFT FR N/E/E/L 20 SQCM/< |
185
|
185
|
|
67966
|
REVISION OF EYELID |
165
|
165
|
|
88332
|
PATH CONSLTJ SURG EA ADD BLK |
142
|
221
|
|
77412
|
RADIATION TX DELIVERY COMPLX |
138
|
140
|
|
J2001
|
LIDOCAINE INJECTION |
135
|
1,957
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C44.1192 related to the following DRG Codes:
124-125
|
